「japan」の検索結果
86件：56～60件目を表示
-
f Licensing Agreement with Brill International Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that it has entered into...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307.pdf -
ion of Marketing Approval for “ Mytear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida) today announces that it has received approval for the marketin...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903_0.pdf -
Treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that the orphan drug des...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708_0.pdf -
Treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that the orphan drug des...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708.pdf -
Research and Development System | Research & Development | SENJU Pharmaceutica
cal package based on sophisticated regulatory strategies while expanding the development regions in Japan and globally, so that we can quickly commercialize the development compounds we create from th...
http://www.senju.co.jp/english/rd/about/